Fox Chase Cancer Center Diagnosis Related Group (DRG) - LOS Quality Outcomes

Fox Chase Cancer Center Diagnosis Related Group (DRG) - LOS Quality Outcomes - Jan 2014 to Mar 2014

Research Diagnosis Related Groups (DRG) level LOS quality outcomes for Fox Chase Cancer Center located at 333 Cottman Ave, Philadelphia, PA, 19111 & includes data from NPIs 1730195017

Dexur analyzed Q1 2014 (January to March 2014) Medicare claims data to benchmark length of stay (LOS) outcomes for Fox Chase Cancer Center compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.

Get Dexur’s Personalized Hospital Specific Presentation on Quality, Safety, Compliance & Education

Data with Symbol is only for Dexur Customers. Get in touch with us to know more.

	Total Hospitalizations (Jan 2014 to Mar 2014)	Total Hospitalizations After Exclusion
All Inpatient	332	321
Surgical	154	152
Non Surgical	178	169
General Surgery	80	79
Oncology & Hematology	70	67
Urology	49	46
General Medicine	27	27
Gastroenterology & Endocrinology	21	21
Colorectal	19	18
Pulmonology	18	17
Orthopedics	17	15
Obstetrics & Gynecology	14	14

General Surgery | Back to Top

Data with Symbol is only for Dexur Customers. Get in touch with us to know more.

	Total Hospitalizations (Jan 2014 to Mar 2014)	Total Hospitalizations After Exclusion	Total Users	Avg. LOS	Pennsylvania Total Hospitalizations (Jan 2014 to Mar 2014)	Pennsylvania Total Hospitalizations After Exclusion	Pennsylvania Total Users	Pennsylvania Avg. LOS	National Total Hospitalizations (Jan 2014 to Mar 2014)	National Total Hospitalizations After Exclusion	National Total Users	National Avg. LOS
Major Chest Procedures
DRG 164: MAJOR CHEST PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC)

Oncology & Hematology | Back to Top

Data with Symbol is only for Dexur Customers. Get in touch with us to know more.

	Total Hospitalizations (Jan 2014 to Mar 2014)	Total Hospitalizations After Exclusion	Total Users	Avg. LOS	Pennsylvania Total Hospitalizations (Jan 2014 to Mar 2014)	Pennsylvania Total Hospitalizations After Exclusion	Pennsylvania Total Users	Pennsylvania Avg. LOS	National Total Hospitalizations (Jan 2014 to Mar 2014)	National Total Hospitalizations After Exclusion	National Total Users	National Avg. LOS
Digestive Malignancy
Malignancy Of Hepatobiliary System Or Pancreas
Chemotherapy Without Acute Leukemia As Secondary Diagnosis
Respiratory Neoplasms

Urology | Back to Top

Data with Symbol is only for Dexur Customers. Get in touch with us to know more.

	Total Hospitalizations (Jan 2014 to Mar 2014)	Total Hospitalizations After Exclusion	Total Users	Avg. LOS	Pennsylvania Total Hospitalizations (Jan 2014 to Mar 2014)	Pennsylvania Total Hospitalizations After Exclusion	Pennsylvania Total Users	Pennsylvania Avg. LOS	National Total Hospitalizations (Jan 2014 to Mar 2014)	National Total Hospitalizations After Exclusion	National Total Users	National Avg. LOS
Kidney And Ureter Procedures

Colorectal | Back to Top

Data with Symbol is only for Dexur Customers. Get in touch with us to know more.

	Total Hospitalizations (Jan 2014 to Mar 2014)	Total Hospitalizations After Exclusion	Total Users	Avg. LOS	Pennsylvania Total Hospitalizations (Jan 2014 to Mar 2014)	Pennsylvania Total Hospitalizations After Exclusion	Pennsylvania Total Users	Pennsylvania Avg. LOS	National Total Hospitalizations (Jan 2014 to Mar 2014)	National Total Hospitalizations After Exclusion	National Total Users	National Avg. LOS
Major Small And Large Bowel Procedures

Orthopedics | Back to Top

Data with Symbol is only for Dexur Customers. Get in touch with us to know more.

	Total Hospitalizations (Jan 2014 to Mar 2014)	Total Hospitalizations After Exclusion	Total Users	Avg. LOS	Pennsylvania Total Hospitalizations (Jan 2014 to Mar 2014)	Pennsylvania Total Hospitalizations After Exclusion	Pennsylvania Total Users	Pennsylvania Avg. LOS	National Total Hospitalizations (Jan 2014 to Mar 2014)	National Total Hospitalizations After Exclusion	National Total Users	National Avg. LOS
Pathological Fractures And Musculoskeletal And Connective Tissue Malignancy